Abstract
The current treatments for bladder cancer are unable to substantially avoid the disease's growth and recurrence, which is a serious public health problem. Researchers have explored a variety of approaches in an effort to effectively replicate the pathophysiology of human tumors using experimental tumor models. The investigation of the available models is a necessary tool in order to choose the most appropriate scheme which serves the translation of potential treatments from a primary experimental bench to the clinical settings. The most suitable murine models of bladder cancer should have excellent reproductivity, intravesical predictability, and accessibility in order to facilitate the mechanistic, chemopreventive, and therapeutic research that can be expanded into clinical trials. This article provides a complete evaluation of both in vitro and in vivo bladder cancer models, comparing their advantages and limitations in urological research.
Keywords: Bladder cancer, Animal models, Cancer cells, Preclinical studies, Implantation, Urological research.
New Emirates Medical Journal
Title:Experimental Animal Models for Preclinical Investigation of the Bladder Cancer
Volume: 5 Issue: 1
Author(s): Sami El Khatib*, Maha Krayem, Sanaa Khaled, Abeer Ayoub and Mohamed Salla
Affiliation:
- Department of Biomedical Sciences, School of Arts & Sciences, Lebanese International University, Lebanon
- Department of Biological Sciences, School of Arts & Sciences, Lebanese International University, Lebanon
- Department of Biological Sciences, School of Arts & Sciences, Lebanese International University, Lebanon
Keywords: Bladder cancer, Animal models, Cancer cells, Preclinical studies, Implantation, Urological research.
Abstract: The current treatments for bladder cancer are unable to substantially avoid the disease's growth and recurrence, which is a serious public health problem. Researchers have explored a variety of approaches in an effort to effectively replicate the pathophysiology of human tumors using experimental tumor models. The investigation of the available models is a necessary tool in order to choose the most appropriate scheme which serves the translation of potential treatments from a primary experimental bench to the clinical settings. The most suitable murine models of bladder cancer should have excellent reproductivity, intravesical predictability, and accessibility in order to facilitate the mechanistic, chemopreventive, and therapeutic research that can be expanded into clinical trials. This article provides a complete evaluation of both in vitro and in vivo bladder cancer models, comparing their advantages and limitations in urological research.
Export Options
About this article
Cite this article as:
El Khatib Sami*, Krayem Maha, Khaled Sanaa, Ayoub Abeer and Salla Mohamed, Experimental Animal Models for Preclinical Investigation of the Bladder Cancer, New Emirates Medical Journal 2024; 5 : e130723218679 . https://dx.doi.org/10.2174/0250688204666230713093742
DOI https://dx.doi.org/10.2174/0250688204666230713093742 |
Print ISSN 0250-6882 |
Publisher Name Bentham Science Publisher |
Online ISSN 0250-6882 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mitochondrial DNA Mutations in Cancer: A Review
Current Topics in Medicinal Chemistry Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In vivo, In vitro and Network Analyses
Recent Patents on Anti-Cancer Drug Discovery Stem Cell Therapy for Ischaemic Stroke: Translation from Preclinical Studies to Clinical Treatment
CNS & Neurological Disorders - Drug Targets Modulation of Matrix Metalloproteinases by Plant-derived Products
Current Cancer Drug Targets Gut Inflammation: Current Update on Pathophysiology, Molecular Mechanism and Pharmacological Treatment Modalities
Current Pharmaceutical Design Current Status of Hedgehog Signaling Inhibitors
Current Topics in Medicinal Chemistry Aim for the Readers! Bromodomains As New Targets Against Chagas’ Disease
Current Medicinal Chemistry Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy
Current Drug Targets To Die or Not to Die: That is the Autophagic Question
Current Molecular Medicine Plant Natural Products in Anticancer Drug Discovery
Current Organic Chemistry Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Triggering PIK3CA Mutations in PI3K/Akt/mTOR Axis: Exploration of Newer Inhibitors and Rational Preventive Strategies
Current Pharmaceutical Design Immunoregulatory and Effector Activities of Nitric Oxide and Reactive Nitrogen Species in Cancer
Current Medicinal Chemistry Targeting Cancer Cells with Photoactive Silica Nanoparticles
Current Pharmaceutical Design Novel Agents Targeting Crucial Signalling Pathways in Head and Neck Squamous Cell Carcinoma, HNSCC - Preclinical Development and Data from Clinical Trials
Current Proteomics Gamma-Oryzanol – A Multi-Purpose Steryl Ferulate
Current Nutrition & Food Science A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists
Current Medicinal Chemistry Molecular and Cellular Mechanism of Cutaneous Injuries Due to Exposure to Sulfur Mustard
Letters in Drug Design & Discovery A Proteomics Study of the Subacute Toxicity of Rat Brain after Long- Term Exposure of <i>Gelsemium elegans</i>
Current Molecular Pharmacology Oxidative Stress, Redox Signaling and Cancer Chemoresistance: Putting Together the Pieces of the Puzzle
Current Medicinal Chemistry